Khiron's First Two CBD Products Now Available At Pharmacies In Peru

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced on Tuesday that it has registered its first two finished cannabis products in Peru.

The company is expanding its Latin American footprint, with commercial operations in territories outside of its home country of Colombia.

Khiron has received a sanitary registration in Peru for Alixen 30 and Alixen 100, two CBD-rich products that will be available for distribution in pharmacies, wholesale distributors and dispensaries.

In Peru, the company sells magistral preparations, or customized compound formulations, …

Full story available on Benzinga.com

More Khiron's First Two CBD Products Now Available At Pharmacies In Peru